|
WO2021046183A1
|
|
Methods of treating epilepsy using the same
|
|
CN110831593A
|
|
Compounds for modulating S1P1 activity and methods of use thereof
|
|
BR112019016827A2
|
|
5-membered azaheterocyclic delta-opioid receptor modulating compounds, methods of use and production thereof
|
|
WO2018152286A1
|
|
7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
|
|
AU2016370860A1
|
|
Combinations of opioid receptor ligands and cytochrome P450 inhibitors
|
|
CN108366997A
|
|
Treat hyperalgesic method
|
|
CN108025002A
|
|
Delta opiate receptor modulating compound containing hexa-atomic aza heterocycles, it is used and preparation method
|
|
WO2016196750A1
|
|
Beta-arrestin effectors and compositions and methods of use thereof
|
|
EP3145524A2
|
|
Synthesis of beta-arrestin effectors
|
|
AU2015213777A1
|
|
Crystalline and amorphous forms of a beta-arrestin effector
|
|
CN104168907A
|
|
Beta-arrestin effectors and compositions and methods of use thereof
|
|
CN103702561A
|
|
Opioid receptor ligands and methods of using and making same
|
|
WO2012075232A1
|
|
Opioid receptor ligands and methods of using and making the same
|
|
CN102333536A
|
|
Ss-arrestin effectors and compositions and methods of use thereof
|
